SKA1–3 mRNA levels were dramatically increased in HCC samples and were significantly correlated with the clinical stage, age, body mass index, tumor grade, tissue subtype, Tp53 mutation status, and prognosis of HCC patients. The gene discussed is TP53; the disease is hepatocellular carcinoma.